Search General Info
Search Education
Search Partnering Companies
June 10-11 & 14-18, 2021
Search General Info
Search Education
Search Partnering Companies
n-Lorem is focused on creating individual treatments for patients in the United States with ultra-rare diseases caused by genetic mutations that affect approximately n1-10 patients in the world. Diseases or conditions with broader patent populations are likely more suitable for treatment by other non-profit or for-profit entities, which we encourage you to explore with your physician.
With a seasoned leadership team and strategic partnerships, the n-Lorem Foundation provides the framework, funds and access for patients with ultra-rare diseases to receive experimental Antisense oligonucleotides (ASOs).
With a seasoned leadership team and strategic partnerships, the n-Lorem Foundation provides the framework, funds and access for patients with ultra-rare diseases to receive experimental Antisense oligonucleotides (ASOs).

Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
United States
Year Founded:
2020
Main Therapeutic Focus:
Lead Product in Development:
Not Provided
Development Phase of Primary Product:
Not Provided
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker

Explore BIO
BIO DOUBLE HELIX SPONSORS







BIO HELIX SPONSORS



1201 Maryland Avenue SW, Suite 900, Washington, DC, 20024 ・ 202-962-9200
© BIO 2021 All Rights Reserved